NeoChord

NeoChord

Signal active

Organization

Contact Information

Overview

NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation.

In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass.

Founded in 2007 and is based in St. Louis Park, MN.

About

Industries

Biotechnology, Health Care, Medical, Medical Device

Founded

2007

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

NeoChord headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $18.7B in funding across 208 round(s). With a team of 11-50 employees, NeoChord is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - NeoChord, raised $5.1M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Ron Nelson

Ron Nelson

CFO

imagePlace David Chung

David Chung

President & CEO

Funding Rounds

Funding rounds

13

Investors

1

Lead Investors

0

Total Funding Amount

$89.9M

Details

6

NeoChord has raised a total of $89.9M in funding over 6 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2012Early Stage Venture850.0K
2015Late Stage Venture20.0M
2009Early Stage Venture3.4M
2011Early Stage Venture5.1M

Investors

NeoChord is funded by 12 investors.

Investor NameLead InvestorFunding RoundPartners
NeoChord-FUNDING ROUND - NeoChord20.0M
Deerfield-FUNDING ROUND - Deerfield20.0M
NeoChord-FUNDING ROUND - NeoChord5.1M
TGap Ventures-FUNDING ROUND - TGap Ventures5.1M

Recent Activity

There is no recent news or activity for this profile.